IFG Advisory LLC Sells 2,152 Shares of The Clorox Company $CLX

IFG Advisory LLC reduced its holdings in shares of The Clorox Company (NYSE:CLX) by 38.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,421 shares of the company’s stock after selling 2,152 shares during the quarter. IFG Advisory LLC’s holdings in Clorox were worth $411,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of CLX. Private Trust Co. NA lifted its stake in shares of Clorox by 16.6% during the 1st quarter. Private Trust Co. NA now owns 2,680 shares of the company’s stock valued at $395,000 after buying an additional 381 shares in the last quarter. Mutual Advisors LLC purchased a new stake in shares of Clorox during the 1st quarter valued at $223,000. D.A. Davidson & CO. raised its position in shares of Clorox by 23.8% during the 1st quarter. D.A. Davidson & CO. now owns 20,107 shares of the company’s stock valued at $2,961,000 after buying an additional 3,871 shares in the last quarter. Avantax Planning Partners Inc. raised its position in shares of Clorox by 24.7% during the 1st quarter. Avantax Planning Partners Inc. now owns 2,471 shares of the company’s stock valued at $364,000 after buying an additional 490 shares in the last quarter. Finally, OneDigital Investment Advisors LLC purchased a new stake in shares of Clorox during the 1st quarter valued at $247,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $112.64 on Monday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a 50-day moving average of $120.49 and a 200-day moving average of $125.82. The firm has a market cap of $13.72 billion, a P/E ratio of 17.28, a P/E/G ratio of 0.92 and a beta of 0.52. The Clorox Company has a 1-year low of $110.61 and a 1-year high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period last year, the company posted $1.82 EPS. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Analyst Ratings Changes

Several research firms have recently weighed in on CLX. Morgan Stanley lowered their price objective on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. Barclays lowered their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a report on Monday, October 13th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $130.20.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.